Kinki University

ACTIVE

大阪府, Japanwww.kindai.ac.jpPrivate1,001–5,000 employeesEstablished: 1943-01-01

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1943

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

37.5%

Phase 1

25.0%

Phase 2

25.0%

Unknown

12.5%

Trial Status Distribution

Completed

50.0%

Not yet recruiting

12.5%

Recruiting

12.5%

Unknown

12.5%

Clinical Trials

Trials sponsored by this organization (8)

JAPANESE PROSPECTIVE REAL WORLD REGISTRY OF CABOZANTINIB PLUS NIVOLUMABIN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMA

Unknown

Recruiting

observational

Nov 202350 participants

Efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease

Not Applicable

interventional

Apr 201610 participants

sefulness of cofocal laser microendoscopy in the diagnosis and treatment of inflammation and cancer

Not Applicable

Not yet recruiting

observational

Oct 201460 participants

Clinical applications of next generation sequencing on therapeutic decision-making in lung cancer

Not Applicable

Completed

observational

Aug 2014234 participants

Phase II study of zoledronic acid concomitant with androgen deprivation therapy for patients with treatment-naive bone-metastatic prostate cancer

Phase 2

Completed

interventional

Mar 201252 participants

Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis

Phase 2

Unknown

interventional

Sep 201020 participants

Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer

Phase 1

Completed

interventional

Sep 20089 participants

Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer

Phase 1

Completed

interventional

Nov 20067 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations